在COVID-19患者中内皮损伤和疾病严重性的生物标志物
Panagiota Tsiatsiou1, Dimitrios Pilalas2, Vasiliki Tsaireli1
1Department of Microbiology, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Current issues in molecular biology
|July 23, 2025
概括
作为评估COVID-19严重程度的可靠生物标志物,即使有病毒突变,P-selectin也具有前景. 在患者组中观察到高水平的P-选择素,·威尔布兰德抗原和VWF瑞斯托塞丁辅因子,在ICU患者中PAI-1和血栓模块素较高.
科学领域:
- * 生物医学研究
- * 传染病病理学
- * 临床诊断 临床诊断
背景情况:
- *由SARS-CoV-2引起的COVID-19需要对疾病严重程度和管理进行持续研究.
- *内皮损伤和凝血异常与严重的COVID-19有关.
- *像P-selectin,血栓模块素 (TM),PAI-1,·威尔布兰特抗原 (VWF:Ag) 和VWF风素辅因子 (VWF:RCo) 这样的生物标志物正在研究它们与疾病严重程度的关联.
研究的目的:
- * 调查COVID-19严重程度与特定的凝血和内皮损伤生物标志物之间的关联.
- * 评估P-selectin作为严重性生物标志物的可靠性,考虑到COVID-19突变.
主要方法:
- *对90名成年COVID-19患者进行了横截面的观察性研究.
- *患者被分为ICU住院,非ICU住院和无症状门诊组.
- *生物标志物P-selectin,PAI-1,TM,VWF:Ag和VWF:RCo使用ELISA和免疫学试验进行测量.
主要成果:
- *在所有患者群体中观察到P-选择素,VWF:Ag和VWF:RCo水平显著升高.
- *ICU患者的PAI-1和TM水平高于非ICU和无症状组,表明内皮损伤增加.
- *发现COVID-19突变显著影响P-选择素水平.
结论:
- *P-selectin成为COVID-19严重程度的潜在更可靠的生物标志物,特别是在不同的临床表现和病毒突变中.
- *升高的PAI-1和TM表明严重的COVID-19病例中的内皮细胞激活和损伤显著.
- *需要进一步进行全面的检查,以了解病毒菌株,感染严重程度和遗传变异对这些生物标志物的影响.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
341
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
341
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
217
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
217
Coronary Artery Disease I: Introduction
59
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
59
Endocarditis II: Clinical Features of Infective Endocarditis
26
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
26


